Sarah James
Stock Analyst at Cantor Fitzgerald
(1.97)
# 3,136
Out of 5,131 analysts
300
Total ratings
35.11%
Success rate
-7.1%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Neutral | $22 → $17 | $13.53 | +25.65% | 18 | Dec 3, 2025 | |
| CNC Centene | Maintains: Neutral | $38 → $41 | $46.61 | -12.04% | 16 | Oct 30, 2025 | |
| CVS CVS Health | Maintains: Overweight | $78 → $95 | $80.30 | +18.31% | 16 | Oct 30, 2025 | |
| UHS Universal Health Services | Maintains: Neutral | $227 → $250 | $207.03 | +20.76% | 27 | Oct 29, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $190 → $245 | $201.20 | +21.77% | 23 | Oct 29, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $210 → $180 | $181.50 | -0.83% | 14 | Oct 24, 2025 | |
| SGRY Surgery Partners | Reiterates: Overweight | $36 | $16.12 | +123.33% | 13 | Oct 7, 2025 | |
| HCAT Health Catalyst | Reiterates: Neutral | $4 | $2.48 | +61.29% | 8 | Oct 7, 2025 | |
| HCA HCA Healthcare | Reiterates: Overweight | $444 | $472.07 | -5.95% | 21 | Oct 7, 2025 | |
| UNH UnitedHealth Group | Reiterates: Overweight | $440 | $343.98 | +27.91% | 18 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $365 | $278.95 | +30.85% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $26.99 | +3.74% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $290 | $276.85 | +4.75% | 21 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $372.83 | +30.09% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $29 | $21.51 | +34.82% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $3.86 | +288.60% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $0.89 | +459.22% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $7.46 | +34.05% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $111.45 | +19.34% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $26.78 | +56.83% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $5.30 | -5.66% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $8.59 | -41.79% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $20.78 | +1.06% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $78.20 | -50.13% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $77.64 | +148.58% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.32 | - | 2 | Mar 1, 2017 |
Acadia Healthcare Company
Dec 3, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $13.53
Upside: +25.65%
Centene
Oct 30, 2025
Maintains: Neutral
Price Target: $38 → $41
Current: $46.61
Upside: -12.04%
CVS Health
Oct 30, 2025
Maintains: Overweight
Price Target: $78 → $95
Current: $80.30
Upside: +18.31%
Universal Health Services
Oct 29, 2025
Maintains: Neutral
Price Target: $227 → $250
Current: $207.03
Upside: +20.76%
Tenet Healthcare
Oct 29, 2025
Maintains: Overweight
Price Target: $190 → $245
Current: $201.20
Upside: +21.77%
Molina Healthcare
Oct 24, 2025
Maintains: Neutral
Price Target: $210 → $180
Current: $181.50
Upside: -0.83%
Surgery Partners
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $16.12
Upside: +123.33%
Health Catalyst
Oct 7, 2025
Reiterates: Neutral
Price Target: $4
Current: $2.48
Upside: +61.29%
HCA Healthcare
Oct 7, 2025
Reiterates: Overweight
Price Target: $444
Current: $472.07
Upside: -5.95%
UnitedHealth Group
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $343.98
Upside: +27.91%
Aug 26, 2025
Reiterates: Overweight
Price Target: $365
Current: $278.95
Upside: +30.85%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $26.99
Upside: +3.74%
May 1, 2025
Reiterates: Neutral
Price Target: $290
Current: $276.85
Upside: +4.75%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $372.83
Upside: +30.09%
Mar 11, 2025
Maintains: Overweight
Price Target: $20 → $29
Current: $21.51
Upside: +34.82%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $3.86
Upside: +288.60%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $0.89
Upside: +459.22%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $7.46
Upside: +34.05%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $111.45
Upside: +19.34%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $26.78
Upside: +56.83%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $5.30
Upside: -5.66%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $8.59
Upside: -41.79%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $20.78
Upside: +1.06%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $78.20
Upside: -50.13%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $77.64
Upside: +148.58%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.32
Upside: -